Could a phone call help rural americans beat colon cancer?
NCT ID NCT05453630
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This study tests whether a remotely-delivered patient navigation program helps more rural adults complete colonoscopy screening for colorectal cancer. Participants aged 45-75 who are due for a colonoscopy receive either navigation support from a trained lay navigator or an educational brochure. The navigator helps schedule the procedure, addresses barriers, and provides coaching. The goal is to see if this approach increases screening rates in underserved rural populations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Patient navigation program (behavioral intervention)
- What this could lead to
- If effective, this program could increase colonoscopy completion rates in rural areas, reducing colorectal cancer deaths through earlier detection.
- What could go wrong
- The trial is relatively small and focuses on a specific population, so results may not apply broadly. Navigation programs also depend on community resources and may not be sustainable long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Washington
Seattle, Washington, 98195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who will survive a bowel surgery leak?
- Can a Two-Drug attack shrink Hard-to-Treat colorectal tumors?
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- A mobile app aims to turn health awareness into action — a trial puts it to the test
- Can a walking routine alter cancer biomarkers? new trial investigates
- Web tool aims to empower rare cancer patients in genomic choices